The Summit will cover topics ‘Exposing Novel Approaches in R&D of the Next-Generation of RNAi Drugs’ and will feature leading speakers from the RNAi field, including: Alnylam, OliX, Sirnaomics, Abbvie and Dicerna. 

Dr Ottosen will chair day one and two of the summit: 

• Day One, 8:55am: Chair’s Opening Remarks
• Day One, 5:00pm: Chair’s Closing Remarks & End of Conference Day One 5:00 pm
• Day Two, 8:50am: Chair’s Opening Remarks 8:50 am
• Day Two, 4:30pm: Chairs Closing Remarks & End of 5th RNAi Based Therapeutics Summit 

‍

Sixfold Biosciences is a biotechnology company solving one of the most critical challenges preventing the greater utilization of powerful RNA medicines: delivery. Sixfold’s solution takes evolution as inspiration, learning and mimicking how RNA is naturally delivered to different cell types in the body. Using advanced AI and Bayesian Optimization, Sixfold is learning the language that encodes RNA-shuttle interactions and destination selection, unlocking new cell types for treatment. 

‍